Clinical Trials Directory

Trials / Completed

CompletedNCT01195168

Cardiovascular Risk Markers in Polycystic Ovary Syndrome (PCOS)

Assessment of Cardiovascular Risk in PCOS-a Cross Sectional Study of Women With PCOS Compared With Controls Matched for Age, Body Mass Index and, or Insulin Resistance

Status
Completed
Phase
Study type
Observational
Enrollment
201 (actual)
Sponsor
The Adelaide and Meath Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Women with polycystic ovary syndrome (PCOS) are more often overweight or obese and are more insulin resistant than women without the condition and may be at greater risk of developing cardiovascular disease. It is not know whether it is the overweight and insulin resistant component of PCOS, or PCOS per se which leads to the greater cardiovascular disease risk. The aim of this study was to examine cardiovascular risk markers in women with PCOS versus a control population matched for body mass index (BMI), and or, insulin resistance

Conditions

Timeline

Start date
2006-11-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2010-09-06
Last updated
2010-09-06

Locations

2 sites across 1 country: Ireland

Source: ClinicalTrials.gov record NCT01195168. Inclusion in this directory is not an endorsement.